• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

角质形成细胞中肿瘤坏死因子相关凋亡诱导配体(TRAIL)的表达介导同种异体T细胞的凋亡性细胞死亡。

Expression of TNF-related apoptosis-inducing ligand (TRAIL) in keratinocytes mediates apoptotic cell death in allogenic T cells.

作者信息

Reimers Kerstin, Radtke Christine, Choi Claudia Y, Allmeling Christina, Kall Susanne, Kiefer Paul, Muehlberger Thomas, Vogt Peter M

机构信息

Department of Plastic, Hand and Reconstructive Surgery, Medical School Hannover Podbielskistraße 380, 30659 Hannover, Germany.

University Duesseldorf, Moorenstrasse 5, 40225 Duesseldorf, Germany.

出版信息

Ann Surg Innov Res. 2009 Nov 19;3:13. doi: 10.1186/1750-1164-3-13.

DOI:10.1186/1750-1164-3-13
PMID:19925644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2790448/
Abstract

The objective of the present study was to evaluate the aptitude of TRAIL gene expression for inducing apoptosis in co-cultivated T-cells. This should allow preparing a strategy for the development of a durable, allogenic skin substitute based on the induction of an immune-privileged transplant. In order to counteract the significant potential of rejection in transplanted allogenic keratinocytes, we created a murine keratinocyte cell line which expressed TRAIL through stable gene transfer. The exogenic protein was localized on the cellular surface and was not found in soluble condition as sTRAIL. Contact to TRAIL expressing cells in co-culture induced cell death in sensitive Jurkat-cells, which was further intensified by lymphocyte activation. This cytotoxic effect is due to the induction of apoptosis. We therefore assume that the de-novo expression of TRAIL in keratinocytes can trigger apoptosis in activated lymphocytes and thus prevent the rejection of keratinocytes in allogenic, immune-privileged transplants.

摘要

本研究的目的是评估TRAIL基因表达诱导共培养T细胞凋亡的能力。这将有助于制定一种策略,以开发基于诱导免疫特权移植的持久同种异体皮肤替代物。为了对抗移植的同种异体角质形成细胞中显著的排斥潜力,我们创建了一种通过稳定基因转移表达TRAIL的小鼠角质形成细胞系。外源性蛋白定位于细胞表面,未发现以可溶性sTRAIL形式存在。共培养中与表达TRAIL的细胞接触会诱导敏感的Jurkat细胞死亡,淋巴细胞激活会进一步加剧这种死亡。这种细胞毒性作用是由于凋亡的诱导。因此,我们认为角质形成细胞中TRAIL的从头表达可触发活化淋巴细胞的凋亡,从而防止同种异体免疫特权移植中角质形成细胞的排斥。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5c/2790448/f9332adbe8e3/1750-1164-3-13-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5c/2790448/d8f6680b4b5a/1750-1164-3-13-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5c/2790448/26b48671c2b5/1750-1164-3-13-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5c/2790448/631abc786a31/1750-1164-3-13-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5c/2790448/ab4eb236cae8/1750-1164-3-13-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5c/2790448/faa14432b9bb/1750-1164-3-13-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5c/2790448/f9332adbe8e3/1750-1164-3-13-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5c/2790448/d8f6680b4b5a/1750-1164-3-13-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5c/2790448/26b48671c2b5/1750-1164-3-13-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5c/2790448/631abc786a31/1750-1164-3-13-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5c/2790448/ab4eb236cae8/1750-1164-3-13-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5c/2790448/faa14432b9bb/1750-1164-3-13-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5c/2790448/f9332adbe8e3/1750-1164-3-13-6.jpg

相似文献

1
Expression of TNF-related apoptosis-inducing ligand (TRAIL) in keratinocytes mediates apoptotic cell death in allogenic T cells.角质形成细胞中肿瘤坏死因子相关凋亡诱导配体(TRAIL)的表达介导同种异体T细胞的凋亡性细胞死亡。
Ann Surg Innov Res. 2009 Nov 19;3:13. doi: 10.1186/1750-1164-3-13.
2
Pathways involved in proliferating, senescent and immortalized keratinocyte cell death mediated by two different TRAIL preparations.由两种不同的TRAIL制剂介导的增殖、衰老和永生化角质形成细胞死亡所涉及的信号通路。
Exp Dermatol. 2002 Dec;11(6):573-83. doi: 10.1034/j.1600-0625.2002.110610.x.
3
cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes.cFLIPL在人角质形成细胞的死亡诱导信号复合物中抑制肿瘤坏死因子相关凋亡诱导配体介导的NF-κB激活。
J Biol Chem. 2004 Dec 17;279(51):52824-34. doi: 10.1074/jbc.M409554200. Epub 2004 Sep 30.
4
Simultaneous inhibition of epidermal growth factor receptor (EGFR) signaling and enhanced activation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-mediated apoptosis induction by an scFv:sTRAIL fusion protein with specificity for human EGFR.一种对人表皮生长因子受体(EGFR)具有特异性的单链抗体片段(scFv):肿瘤坏死因子相关凋亡诱导配体(TRAIL)融合蛋白同时抑制表皮生长因子受体(EGFR)信号传导并增强肿瘤坏死因子相关凋亡诱导配体(TRAIL)受体介导的凋亡诱导激活。
J Biol Chem. 2005 Mar 18;280(11):10025-33. doi: 10.1074/jbc.M413673200. Epub 2005 Jan 11.
5
Role of NF-kappaB activity in apoptotic response of keratinocytes mediated by interferon-gamma, tumor necrosis factor-alpha, and tumor-necrosis-factor-related apoptosis-inducing ligand.核因子-κB活性在干扰素-γ、肿瘤坏死因子-α及肿瘤坏死因子相关凋亡诱导配体介导的角质形成细胞凋亡反应中的作用
J Invest Dermatol. 2001 Oct;117(4):898-907. doi: 10.1046/j.0022-202x.2001.01477.x.
6
DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.DR4特异性TRAIL变体在胰腺癌中比野生型TRAIL更有效。
Cancer Biol Ther. 2014;15(12):1658-66. doi: 10.4161/15384047.2014.972183.
7
Immunotherapy with liposome-bound TRAIL overcomes partial protection to soluble TRAIL-induced apoptosis offered by down-regulation of Bim in leukemic cells.用脂质体结合的肿瘤坏死因子相关凋亡诱导配体(TRAIL)进行免疫治疗,克服了白血病细胞中Bim下调对可溶性TRAIL诱导凋亡所提供的部分保护作用。
Clin Transl Oncol. 2015 Aug;17(8):657-67. doi: 10.1007/s12094-015-1295-x. Epub 2015 May 13.
8
Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production.干扰素-γ是角质形成细胞(HaCaT)凋亡的主要介质,并有助于自分泌干扰素-γ和肿瘤坏死因子-α的产生。
Br J Dermatol. 2005 Jun;152(6):1134-42. doi: 10.1111/j.1365-2133.2005.06508.x.
9
Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.活化的人类自然杀伤细胞和CD8 + T细胞同时表达肿瘤坏死因子相关凋亡诱导配体(TRAIL)和TRAIL受体,但对TRAIL介导的细胞毒性具有抗性。
Blood. 2004 Oct 15;104(8):2418-24. doi: 10.1182/blood-2004-04-1294. Epub 2004 Jun 17.
10
Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.雷帕霉素、环孢素A以及磷脂酰肌醇3激酶、蛋白激酶C和蛋白酪氨酸激酶的抑制剂可阻断T细胞活化诱导的小鼠TRAIL(肿瘤坏死因子相关凋亡诱导配体)表达:通过T细胞受体信号通路诱导TRAIL的证据。
Exp Cell Res. 1999 Oct 10;252(1):96-103. doi: 10.1006/excr.1999.4631.

引用本文的文献

1
Current and emerging biomarkers of cell death in human disease.人类疾病中细胞死亡的当前及新出现的生物标志物
Biomed Res Int. 2014;2014:690103. doi: 10.1155/2014/690103. Epub 2014 May 18.

本文引用的文献

1
Role of CD4+ and CD8+ T cells in murine skin and heart allograft rejection across different antigenic desparities.CD4+和CD8+ T细胞在不同抗原差异的小鼠皮肤和心脏同种异体移植排斥反应中的作用。
Transpl Immunol. 2004 Dec;13(4):297-304. doi: 10.1016/j.trim.2004.10.005.
2
Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes.肿瘤坏死因子相关凋亡诱导配体的腺病毒基因转移克服了肝癌细胞受损的反应,但导致原代人肝细胞严重凋亡。
Cancer Res. 2003 May 15;63(10):2369-72.
3
FasL-transfected endothelial cells decrease the proliferative response of allogeneic PBL.
Transpl Immunol. 2002 Nov;10(4):293-302. doi: 10.1016/s0966-3274(02)00073-4.
4
Functional expression of tumor necrosis factor-related apoptosis-inducing ligand in human colonic adenocarcinoma cells.肿瘤坏死因子相关凋亡诱导配体在人结肠腺癌细胞中的功能性表达
Lab Invest. 2002 Sep;82(9):1111-9. doi: 10.1097/01.lab.0000027838.69455.39.
5
Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack.活化诱导的细胞死亡:Fas和Fas配体在免疫豁免和肿瘤反击中的争议性作用。
Immunol Cell Biol. 2002 Apr;80(2):131-7. doi: 10.1046/j.1440-1711.2002.01068.x.
6
The molecular architecture of the TNF superfamily.肿瘤坏死因子超家族的分子结构
Trends Biochem Sci. 2002 Jan;27(1):19-26. doi: 10.1016/s0968-0004(01)01995-8.
7
Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells.人T细胞激活诱导死亡过程中携带Fas配体或APO2配体/肿瘤坏死因子相关凋亡诱导配体的微泡的差异分泌
J Immunol. 2001 Dec 15;167(12):6736-44. doi: 10.4049/jimmunol.167.12.6736.
8
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions.重组Apo2L/TRAIL不同版本的肝细胞毒性差异
Nat Med. 2001 Apr;7(4):383-5. doi: 10.1038/86397.
9
Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection.心脏、皮肤和胰岛同种异体移植对T细胞介导排斥反应的易感性差异。
J Immunol. 2001 Feb 15;166(4):2824-30. doi: 10.4049/jimmunol.166.4.2824.
10
Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis.Fas反击诱导人结直肠癌肿瘤浸润淋巴细胞凋亡的频率及其与预后的相关性
Clin Cancer Res. 2000 Sep;6(9):3560-4.